The long-term goals of this project are to examine the mechanism of ER regulation in reproductive tissue. Much of the earlier work has focused on the Xenopus laevis ER and this proposal continues some of these studies, but emphasizes studies of the structure and function of the human ER.
Aim 1 is to test the hypothesis that tighter binding to the ERE in ER mutants partially activates the ER, resulting in estrogen-independent transcription by the ER, and enabling antiestrogens to activate the ER. To accomplish this, ER mutants will be produced exhibiting enhanced binding to ERE using a bacteriophage P22 challenge phage system. The relative affinity for the ERE will be correlated with the estrogen independent activity and antiestrogen activation. Finally, the role of the affinity of the ER for the ERE in ER phosphorylation by a DNA- dependent kinase will be examined.
Aim 2 is to determine whether intrinsically bent DNA near the vitellogenin EREs potentiates the ability of the EREs to activate transcription.
Aim 3 is to determine if intrinsic DNA bending sequences within the ERE can influence the ability of ER to bind to the ERE and to activate transcription.
Aim 4 will identify the DNA sequences and mechanisms responsible for the developmental induction of XER mRNA and the long-term autoregulation of XER gene expression.
Aim 5 will examine the role of chromatin assembly in transcriptional silencing of the vitellogenin promoter, determine whether unliganded ER or ER complexed to antiestrogens can bind to ERE- containing chromatin, and the role of the two ER transactivation domains in the transcription of chromatin templates.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
2R01HD016720-14
Application #
2197351
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1982-07-01
Project End
2000-03-31
Budget Start
1995-04-01
Budget End
1996-03-31
Support Year
14
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Illinois Urbana-Champaign
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
041544081
City
Champaign
State
IL
Country
United States
Zip Code
61820
Zhou, Jian-Hua; Yu, David V; Cheng, Jingwei et al. (2007) Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death. Steroids 72:765-77
Cheng, Jingwei; Yu, David V; Zhou, Jian-Hua et al. (2007) Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-induced apoptosis. J Biol Chem 282:30535-43
Cheng, Jingwei; Zhang, Chen; Shapiro, David J (2007) A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen. Endocrinology 148:4634-41
Jiang, X; Ellison, S J; Alarid, E T et al. (2007) Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells. Oncogene 26:4106-14
Wang, Stanley; Zhang, Chen; Nordeen, Steven K et al. (2007) In vitro fluorescence anisotropy analysis of the interaction of full-length SRC1a with estrogen receptors alpha and beta supports an active displacement model for coregulator utilization. J Biol Chem 282:2765-75
Jiang, Xinguo; Orr, Brent A; Kranz, David M et al. (2006) Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells. Endocrinology 147:1419-26
Krieg, Adam J; Krieg, Sacha A; Ahn, Bonnie S et al. (2004) Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes. J Biol Chem 279:5025-34
Wang, Stanley Y; Ahn, Bonnie S; Harris, Rebecca et al. (2004) Fluorescence anisotropy microplate assay for analysis of steroid receptor-DNA interactions. Biotechniques 37:807-8, 810-7
Kannan-Thulasiraman, Padma; Shapiro, David J (2002) Modulators of inflammation use nuclear factor-kappa B and activator protein-1 sites to induce the caspase-1 and granzyme B inhibitor, proteinase inhibitor 9. J Biol Chem 277:41230-9
Krieg, S A; Krieg, A J; Shapiro, D J (2001) A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1beta- converting enzyme (caspase 1). Mol Endocrinol 15:1971-82

Showing the most recent 10 out of 47 publications